BioSpace News Archive

Dr. Reddy’s Laboratories Ltd. today announced the launch of Deferasirox Tablets for Oral Suspension, a therapeutically equivalent generic version of Exjade® Tablets for Oral Suspension, approved by the U.S. Food and Drug Administration.

Applied Therapeutics Inc. (Nasdaq:APLT), today announced the presentation of data at the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) in Los Angeles (December 4-7, 2019) on AT-001, a novel, potent and selective aldose reductase inhibitor (ARI) in Phase 3 clinical development for Diabetic Cardiomyopathy (DbCM).

Everlywell, the digital health company poised to disrupt the 25 billion dollar lab testing industry, today announced the addition of several members to its Scientific Advisory Board and the appointment of its first independent board member, Dr. Judith Rodin.

Health-Minded, Mission-Focused, and Inclusive Environment Among Reasons for Selection

Kit Check, the leader in automated medication management solutions for hospitals, today announced an expansion of their continued partnership with MPI Labels, a leader in custom RFID label printing and encoding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today issued the following statement on behalf of the Board of Directors and management team

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, announced today that it will provide updates on its proprietary, neurology programs at the American Epilepsy Society (AES) Annual Meeting held in Baltimore, MD.